Health and Human Services Department, Food and Drug Administration
The Food and Drug Administration (FDA or Agency) is requesting nominations for qualified individuals to serve as voting members of FDA's standing public advisory committees and panels (collectively, advisory committees). This notice covers scientific, technical, professional, and other voting-member positions in which appointees serve as individuals rather than as designated representatives; it does not solicit nominations for consumer representative or industry representative positions. FDA will consider nominations for current and future vacancies as they arise. FDA encourages nominations of all appropriately qualified candidates whose expertise and perspectives would contribute to the work and balanced composition of its advisory committees.
Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Health and Human Services Food and Drug Administration [Docket No. FDA-2026-N-0008] AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA or Agency) is requesting nominations for qualified individuals to serve as voting members of FDA's standing public advisory committees and panels (collectively, advisory committees). This notice covers scientific, technical, professional, and other voting-member positions in which appointees serve as individuals rather than as designated representatives; it does not solicit nominations for consumer representative or industry representative positions. FDA will consider nominations for current and future vacancies as they arise. FDA encourages nominations of all appropriately qualified candidates whose expertise and perspectives would contribute to the work and balanced composition of its advisory committees. DATES: FDA accepts nominations on a continuing basis. Nominations received on or before November 30, 2026 will be given first consideration for current and near-term vacancies. Nominations received after that date will be considered as later vacancies arise. ADDRESSES: Submit nominations electronically through the FDA Advisory Committee Membership Nomination Portal at https://www.accessdata.fda.gov/​scripts/​FACTRSPortal/​FACTRS/​index.cfm and, for positions covered by this notice, select “Academician/Practitioner” as the membership type…
Other Federal Register documents from the same docket.
Advisory Committee; Cellular, Tissue, and Gene Therapies Advisory Committee; Renewal
Advisory Committee; Antimicrobial Drugs Advisory Committee; Renewal
Advisory Committee; Dermatologic and Ophthalmic Drugs Advisory Committee; Renewal
Request for Nominations for Individuals and Consumer Organizations for Advisory Committees
Advisory Committee; Oncologic Drugs Advisory Committee; Renewal
Citation: 91 FR 62527
